Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M27.6Revenue (TTM) $M--Net Margin (%)--Altman Z-Score-2.3
Enterprise Value $M3.3EPS (TTM) $-1.4Operating Margin %--Piotroski F-Score2
P/E(ttm)--Beneish M-Score--Pre-tax Margin (%)--Higher ROA y-yN
Price/Book1.110-y EBITDA Growth Rate %--Quick Ratio7.6Cash flow > EarningsY
Price/Sales--5-y EBITDA Growth Rate %18.6Current Ratio7.6Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-83.7Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-96.8Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M19.7ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with ONCS

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

ONCS is held by these investors:



ONCS: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Mohan-Peterson SheelaChief Legal&Compliance Officer 2017-01-31Buy3,000$0.9941.41view
DHILLON PUNITPresident and CEO 2017-01-31Buy3,000$0.9941.41view
DHILLON PUNITPresident and CEO 2016-07-31Buy3,000$1.44-2.78view
Mohan-Peterson SheelaCL&CO 2016-07-31Buy3,000$1.44-2.78view
DHILLON AVTAR SDirector 2015-10-16Buy10,000$4.36-67.89view
Mohan-Peterson SheelaChief Legal Officer 2015-10-16Buy520$4.24-66.98view
DHILLON PUNITPresident and CEO 2015-10-16Buy10,000$4.25-67.06view
SLANSKY RICHARD BCFO 2015-07-06Buy150,000$6.12-77.12view
DHILLON PUNITPresident and CEO 2015-06-10Buy2,500$6.74-79.23view
MAIDA ANTHONY E IIIDirector 2014-03-20Buy1,140$16.2-91.36view

Press Releases about ONCS :

Quarterly/Annual Reports about ONCS:

News about ONCS:

Articles On GuruFocus.com

More From Other Websites
OncoSec to Present New Clinical Data from Phase 2 Combination Study at ASCO-SITC Clinical... Feb 08 2017
OncoSec to Present at NobleCon13 Jan 26 2017
OncoSec to Present at Investment Conferences in January Jan 03 2017
LifeSci Capital Initiates Coverage of OncoSec Medical Dec 27 2016
ONCOSEC MEDICAL INC Files SEC form 8-K, Unregistered Sale of Equity Securities, Change in Directors... Dec 16 2016
The Unassuming Industry Set to Benefit From President Obama’s Final Move? Dec 16 2016
ONCOSEC MEDICAL INC Financials Dec 14 2016
ONCOSEC MEDICAL INC Files SEC form 10-Q, Quarterly Report Dec 08 2016
ONCOSEC MEDICAL INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Dec 08 2016
OncoSec Announces First Quarter Financial Results for Fiscal Year 2017 Dec 08 2016
Q1 2017 OncoSec Medical Inc Earnings Release - Before Market Open Dec 08 2016
ONCOSEC MEDICAL INC Files SEC form 8-K, Change in Directors or Principal Officers, Submission of... Dec 07 2016
OncoSec to Present at the 9th Annual LD Micro Main Event Dec 01 2016
OncoSec Announces Key Corporate Initiatives at Inaugural Investor & Analyst Day on November 17, 2016 Nov 17 2016
OncoSec to Host First Quarter Financial Results Conference Call on December 8, 2016 Nov 15 2016
OncoSec to Host First Quarter Financial Results Conference Call on December 8, 2016 Nov 15 2016
OncoSec Presents Positive Interim Response Data at the Society for Immunotherapy of Cancer (SITC)... Nov 11 2016
OncoSec Announces Positive Interim Response Data at the Society for Immunotherapy of Cancer (SITC)... Nov 08 2016
OncoSec to Present at Scientific and Investment Conferences and to Host Inaugural Investor and... Nov 01 2016
OncoSec Rallies 13% on Huge Volumes (ONCS) Oct 28 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)